baber/WOPTO huggingface dataset:
Patent DE-602006021221-D1 (DE)
Inventor: BOBBERT ILJA
IPC: C02F1/46
Filed: 2006-10-25
Abstract: The present invention discloses an activated biocidal aqueous solution containing hydrogen peroxide (activated peroxide solution) obtainable by subjecting an initial solution of hydrogen peroxide in water to a non-thermal electrical discharge process, such as a glow discharge plasma or a corona discharge. The resulting activated peroxide solution containing 0.05 to 20% (w/w) hydrogen peroxide has a pH in the range of 2 to 4, an oxidation-reduction potential (ORP) in the range of 400 to 600 mV, and the solution when having a peroxide content in the range of 0.05% to 0.5% (w/w) has a conductivity in the range of 100 to 500 μSiemens/cm, the solution when having a peroxide content in the range of 0.1% to 5% (w/w) has a conductivity in the range of 100 to 450 μSiemens/cm, and the solution when having a peroxide content in the range of 5% to 20% (w/w) has a conductivity in the range of 100 to 350 μSiemens/cm. The pH, ORP and conductivity are measurable under conditions essentially without the presence of additional compounds in the solution. The biocidal activity of the solution is substantially higher than that of a common peroxide solution. The biocidal solution may be used for any purpose where disinfecting and/or sanitizing and/or cleaning and/or bleaching and/or preservative activity is required. The present invention further discloses a non-thermal electrical discharge process, in particular a pulsed corona induced low frequency pulsed DC plasma discharge process, for the preparation of the activated peroxide solution.
Patent DE-602007004737-D1 (DE)
Inventor: RANTA CRAIG ERIC
IPC: H04S7/00
Filed: 2007-11-02
Abstract: A degree of seal of an ear about a speaker port may be estimated by detecting touch contact between the ear and at least one touch sensor in fixed relation to the speaker port. The degree of seal is estimated based on the detected touch contact. Based upon the estimated degree of seal, the acoustic output of the speaker may be adjusted. The adjustment may compensate for perceived changes to the quality of the acoustic output resulting from the degree of seal. The at least one touch sensor may be a plurality of touch sensors spaced around the speaker port. Each sensor may have a truncated wedge shape, with a narrow end closest to the speaker port.
Patent DE-602009001010-D1 (DE)
Inventor: GOHIER ERIC
IPC: G21F7/005
Filed: 2009-02-11
Abstract: The device has a connection unit formed of external clamp (5) and annular clamp, to connect a container (1) and an enclosure, respectively. An integration unit formed of peripheral clamp (9), fixed mold (12), movable mold (15) and central mold integrates a lid (2) and a door (16) of the container and enclosure, respectively. The mold (15) of predefined shape provided on the door cooperates with the fixed mold situated on the lid, where the fixed mold has a shape complementary to that of the movable mold. A lock (25) prevents disintegration of the container and enclosure when the door is open.
Patent DE-19981587-D2 (DE)
Inventor: MADAUS STEFAN
IPC: A61M16/00
Filed: 1999-08-19
Granted: 2002-01-10
Abstract: A method and a device for switching to the inspiration or expiration phase during CPAP therapy are disclosed. By means of a first high threshold value and a second low threshold value non-specific influences on the first derivative of the gas flow curve are suppressed in the corresponding breathing phase and the transition to the corresponding following gas phase is determined with high sensitivity. The invention further relates to methods for recognizing and suppressing the influence of the pulse or for switching to the inspiration phase in case of shallow breathing. The advantages of the invention are greater switching accuracy and improved safety for the patient.
Patent MD-703-F1 (MD)
Title: Process for keeping of the sire bulls in the period of sperm productivity lowering
Inventor: FURDUI TUDOR
IPC: A61D19/02
Filed: 1996-08-06
Abstract: The invention relates to the animals reproduction field, particularl= y, to the gametogenesis, mainly, to the spermatogenesis. The summary of the invention consists in the fact that the sire bulls are subjected in the period of the sperm productivity lowering to the stress which is carried out by keeping them in the darkness during 7 days and introducing in their ration exclusively the water,on the eighth day the animals are getting 1/3 of the day ration, on the ninth day -1/2 of the d= ay ration and beginning from the tenth day they are getting the full value day ration. The technical result of the invention consists in the improving of the si= re bulls sperm morphophysiological effect in the period of the sperm productivity lowering. Claims: 1
Patent MD-1864-F1 (MD)
Title: Liqueur
Inventor: BABII SERGIU
IPC: C12G3/00
Filed: 2000-08-21
Abstract: The invention relates to the alcoholic beverage industry, namely to a liqueur composition with the following component ratio, dal to 1000 dal of blending: cherry infusion in sugar syrop   295...305almond infusion in hydroalcoholic solution 2,5...5,0almond infusion in 3...5 year divine  2,5...5,0sugar syrop 73,2%   225...235hydroalcoholic solution of highly refined ethyl alcohol and softened water - the rest, up to a strength of 30 (+,-)0,5% vol.The result consists in attributing the final product a velvety-mellow taste with fine aroma and in improving its quality.Claims: 1
Patent MD-1173-G2 (MD)
Title: Process for extraction of nonferrous metals from sewage sludges
Inventor: COVALIOVA OLGA
IPC: C02F11/14
Filed: 1998-04-24
Abstract: The invention relates to the nonferrous and precious metals extraction technology from sludges resulting from the sewage treatment and can be used in the galvanic productions and hydrometallurgy.The summary of the invention consists in the fact that in the process, including the nonferrous metals compounds dissolution with the subsequent reduction of the metals by means of reducers during the magnetic liquefaction, the dissolution is conducted at pH = 8…10 and a temperature of 40…70°C in the solution comprising, g/L:In the capacity of reducers it is used a mixture comprising of hydrazine hydrate, formalin and sodium borohydride taken in the volume ratio of respectively (10…20): (5…10): 1, the metals reduction is conducted with the application of continuous electric current of 3…12 V, for the electric plasma-chemical action on the solution and the magnetic liquefaction is carried out in the rotatable electromagnetic field utilizing cylindrical bodies with a length of 0,45…0,55 from the distance dimension between the electrodes made of magnetic soft material coated with a nickel-cobaltous catalyst layer.The technical result consists in the selective dissolution of metals and in the mass transfer intensification.
Patent LU-C00153-I1 (LU)
Filed: 2020-05-08
Abstract: The present disclosure provides prodrugs of biologically active 2,4-pyrimidinediamine compounds, compositions comprising the prodrugs, intermediates and methods for synthesizing the prodrugs and methods of using the prodrugs in a variety of applications.
Patent LU-88272-I2 (LU)
IPC: C07K14/00
Filed: 1980-06-10
Abstract: Nonapeptide and decapeptide analogs of LH-RH of the formula (pyro)Glu-His-V-Ser-W-X-Y-Arg-Pro-Z (I) and the pharmaceutically acceptable salts thereof wherein: V is tryptophyl, phenylalanyl or 3-(1-naphthyl)-L-alanyl; W is tyrosyl, phenylalanyl or 3-(1-pentafluorophenyl)-L-alanyl; X is a D-amino acid residue <IMAGE>   wherein R is (a) a carbocyclic aryl-containing radical selected from the group consisting of naphthyl, anthryl, fluorenyl, phenanthryl, biphenylyl, benzhydryl and phenyl substituted with three or more straight chain lower alkyl groups; or (b) a saturated carbocyclic radical selected from the group consisting of cyclohexyl substituted with three or more straight chain lower alkyl groups, perhydronaphthyl, perhydrobiphenylyl, perhydro-2,2-diphenylmethyl and adamantyl; Y is leucyl, isoleucyl, nor-leucyl or N-methyl-leucyl; Z is glycinamide or -NH-R1, wherein R1 is lower alkyl, cycloalkyl, fluoro lower alkyl or   <IMAGE>  wherein R2 is hydrogen or lower alkyl, are disclosed. These compounds exhibit potent LH-RH agonist properties.
Patent LU-88801-I2 (LU)
IPC: C07D217/10
Filed: 1985-07-17
Abstract: Neuromuscular blocking agents of formula (1) which are useful as skeletal muscle relaxants during surgery are disclosed.   <IMAGE> (1) <IMAGE>  and X is an anion, preferably pharmaceutically acceptable.
Patent FR-07C0056-I2 (FR)
IPC: A61K31/4439
Filed: 2007-11-05
Granted: 2008-05-09
Abstract: Substituted 2-(2,6-dioxopiperidin-3-yl)phthalimides and 1-oxo-2-(2,6-dioxopiperidin-3-yl)isoindolines reduce the levels of TNF± in a mammal. Typical embodiments are 1-oxo-2-(2,6-dioxo-3-methylpiperidin-3-yl)-4,5,6,7-tetrafluoroisoindoline and 1,3-dioxo-2-(2,6-dioxo-3-methylpiperidin-3-yl)-4-aminoisoindoline.
Patent ES-2411805-R1 (ES)
Title: Sistema de alimentacion automatica para maquinas flejadoras.
Inventor: BERNABEU VIDAL ANTONIO
IPC: B65B13/18
Filed: 2011-12-02
Abstract: Sistema de alimentación automática para máquinas flejadoras. Aplicable a máquinas flejadoras (1) asistidas por una línea de alimentación (2) motorizada, la invención prevé la inclusión de un pórtico (6), por el que son pasantes los bloques de embalajes (4), y sobre el que se establece un lector láser (7) de medición de las dimensiones en planta de dichos bloques, asistido por el correspondiente equipo informático, de manera que junto a la línea de alimentación se establece un robot (9), cuyo brazo articulado está asociado a un cabezal transportador de tapas, ya sean planchas o saldos de cartón, así como tableros, con unas dimensiones que le confieran un margen de maniobra para operar sobre diferentes zonas de apilamiento de saldos/tapas/tableros de distintas dimensiones, así como sobre la línea de alimentación (2), y sobre una mesa formadora (12), dotada de medios de doblado automático a medida de las tapas o saldos en función de la anchura de los bloques de embalaje (14) entrantes a la línea de alimentación.
Patent ES-2585605-R1 (ES)
Title: Estructura de anclaje para fijación de paneles solares
Inventor: FERNANDEZ-FONT PEREZ JAVIER
IPC: E04D13/18
Filed: 2016-04-12
Abstract: Estructura de anclaje para fijación de paneles solares, en particular sobre techos con planchas (7) engargoladas formando resaltes (6) con remate (61) superior, formada por una pieza de apriete (2) y una pieza de apoyo grapa (3) unidas mediante tornillos (4) y tuercas (5); que presentan configuración simétrica, en su parte inferior, que se adapta a ambos lados de los resaltes (6) para fijarse a presión; y la pieza de apoyo grapa (3) una ranura (12) superior apta para recibir un tornillo y quedar bloqueado en el interior de la misma. La parte inferior de la pieza de apriete (2) y de la pieza de apoyo grapa (3) presentan un abultamiento (8) que determina un hueco (9) donde queda alojado el remate (61) del resalte (6), y un tramo recto (10), cuya superficie interna (11) es dentada.
Patent CL-2008003774-S1 (CL)
Title: Palo para helado, constituido por una placa de contorno eliptico de extremo superior ahusado y extremo inferior truncado horizontal plano, las paredes laterales, superior e inferior incluyen una arista perimetral redondeada que en la pared posterior presenta dos escalones perimetrales y zona centralhundida.
Inventor: ACUNZO VINCENZO
Filed: 2008-12-17
Abstract: Barra para helado.
Patent SI-0934065-T1 (SI)
Title: Novel cryptophycin derivatives as anti-neoplastic agents
Inventor: AL-AWAR RIMA S
IPC: A61K31/395
Filed: 1997-08-29
Abstract: The invention provides novel cryptophycin compounds which can be useful for disrupting the microtubulin system, as anti-neoplastic agents, and for the treatment of cancer. The invention further provides a formulation for administering the novel cryptophycin compounds.
Patent TR-199701567-T1 (TR)
Inventor: COTTENS SYLVAIN
IPC: A61P29/00
Filed: 1996-06-05
Abstract: 32 (S)-dihidro-rapamisin türevleri ve 32-deokso-rapamisin bilesikleri arasindan seçilen rapamisin türevleri ilgi çekici eczasal özelliklere sahiptir.
Patent AT-E309026-T1 (AT)
Inventor: BAUDINO MICHAEL
IPC: A61N1/372
Filed: 2000-04-03
Granted: 2005-11-15
Abstract: The present invention discloses techniques capable of selectively affecting and adjusting a volume of neural tissue in the brain, parenchyma of the spinal cord, or a peripheral nerve. The invention preferably utilizes a lumen having at least one opening at its distal end that is capable of directing a lead outwardly along a predetermined trajectory. The lumen is capable of accepting a plurality of leads that can project outward in different directions from the distal end of the lumen. The leads have one or more electrodes at its ends and are thereby configured by the lumen in accordance with a predetermined two- or three-dimensional geometry. Anode/cathode relationships may be then established between the electrodes as desired by the operator to stimulate the neural tissue surrounding these electrodes. The operator may also adjust the stimulation to selectively stimulate the desired portion of the brain, spinal cord, peripheral nerve. In other embodiments, the present invention may be implemented to provide drug infusion. Sensor feedback may be implemented to adjust the treatment therapy. <IMAGE>
Patent AT-E260834-T1 (AT)
Inventor: TOURRE CHRISTIAN
IPC: B65D75/58
Filed: 2000-05-11
Granted: 2004-03-15
Abstract: The pack (20), made from a sheet of a supple e.g. plastics material with an opening that allows at least one handkerchief to be seized to pull it out, has a height (H3) and width (L3) of the same dimensions (50 to 58 mm) to give the pack square front (22) and rear (24) faces. The handkerchiefs (64) inside the pack are folded into squares, each with a multiple of four thicknesses. The opening can be in the form of a front flap (36) or perforated corner.
Patent AT-E263481-T1 (AT)
Inventor: CLAUSS MARC
IPC: A01G13/02
Filed: 2000-09-29
Granted: 2004-04-15
Abstract: The procedure consists of covering the asparagus plants (10) with a tunnel cloche made from opaque plastic film (20) which absorbs heat and creates a greenhouse effect. The lengthwise edges (26) of the film are hemmed and weighted, and it is fitted over a series of arches (22) and removed for harvesting by a tractor-mounted or towed implement with a series of horizontal rollers set at right angles to the direction of travel and having an inverted V formed by two rollers at the back. At least one of the rollers is driven to move the film towards the rear by friction.
Patent AT-E258121-T1 (AT)
Inventor: LANDHOLM STEFAN
IPC: B60G21/055
Filed: 2000-06-16
Granted: 2004-02-15
Abstract: A two-part bush (13a,13b) intended for vehicle anti-roll stabiliser means (11), wherein each of the bush parts is comprised of elastomeric material, for instance rubber, and optionally also includes an inner reinforcement. The bush parts (13a,13b) are together intended to embrace a shaft or like element of circular cross-section and are shaped to this end. According to the invention, each part of the bush is adapted to embrace the circumference of the shaft through an angle greater than 180 DEG  and is constructed so as to enable it to be clamped firmly to said shaft or said element when fitting the bush thereto. One end of each bush-part has a tapered shape (14) and the other end has a recess (16) that is shaped to accommodate said tapered end. The tapered end of each bush part may be V-shaped or U-shaped and the outer extremity (15) of each tapered bush part is preferably straight. Each bush part is preferably resilient or springy and may have a metal element baked in the elastomeric material.  <IMAGE>
Patent AT-E402261-T1 (AT)
Inventor: HILDT EBERHARD
IPC: A61P43/00
Filed: 2000-02-04
Granted: 2008-08-15
Abstract: The present invention relates to particles, comprising: a protein envelope with a fusion protein, which comprises a virus protein, a cell permeability-mediating peptide and a heterologous cell-specific binding site; and a nucleic acid present in the protein envelope, which comprises the sequence for a virus-specific packaging signal and a structural gene. The invention further relates to methods for the preparation of such particles and means suitable for this purpose, as well as the use of the particles in gene therapy.
Patent AT-E367633-T1 (AT)
Inventor: PALMER GLEN
IPC: F21V8/00
Filed: 2000-03-27
Granted: 2007-08-15
Abstract: A display device for use in an illuminated display system has a transparent medium (22) with the first and second opposing surfaces (24, 25) to be illuminated in use. At least one (24) of the first and second opposing surfaces has a matrix (30) of spots (32) each having a hollow transparent interior (33) substantially covering at least a major portion of surface to be illuminated for providing an even and increased illumination throughout that portion of the respective surface. The matrix of spots does not form a part of a message or information to be illuminated.
Patent AT-E234346-T1 (AT)
Inventor: BAKKEREN FRANK JOHANNES ALFRED
IPC: C09D191/00
Filed: 2000-04-14
Granted: 2003-03-15
Abstract: Coating composition comprising:   c.   one or more thiol compounds; d.   one or more oxidatively drying polyunsaturated condensation products of one or more fatty acids and/or esters, one or more polyols and optionally one or more polycarboxylic acids and/or anhydrides of polycarboxylic acids and optionally other building blocks; d.   and one or more photo-initiators. The ratio between the number of unsaturated groups and the number of SH-functional groups is preferably between 2:1 and 20:1. Preferably, the photoinitiator is a mono-, bis- or trisacyl phosphine oxide or a mixture thereof. The coating composition according to the invention can be used a one component coating system, preferably as a high solids coating composition, comprising 0 - 30 wt.% solvents, or as an aqueous coating composition.
Patent AT-E276608-T1 (AT)
Inventor: WILLER BERND
IPC: H03H7/09
Filed: 2000-04-03
Granted: 2004-10-15
Abstract: A power line filter connected to single-phase power lines (110-230 VAC, 50-60 Hz) enables transmission of HomePNA-type home network signals between network nodes connected to the main power lines as a network medium. The filter includes fuse resistors (R1, R2) that limit the current from the main power line, a transit diode circuit that clamps the bolts to a prescribed limit, eliminating energy that may be present in main power spikes. A pair of X2-type capacitors pass the 1 MHz or higher HomePNA signals, while rejecting the 50-60 Hz main power signal. A choke-type inductor eliminates any residual high voltage signals in the 50-60 Hz range by short circuiting the power signals, while maintaining a high impedance at the 1 MHz range, enabling the HomePNA signals to be safely passed to the RJ-11 connector of a physical layer transceiver of the Home Network Node.
Patent AT-E418321-T1 (AT)
Inventor: BERTZ STEVEN
IPC: A61K8/30
Filed: 2000-04-05
Granted: 2009-01-15
Abstract: What is shown is a high purity adduct of castor oil and a cyclic carboxylic acid anhydride, charactered by the absence of free acid anhydride, which is used in personal care products. The adduct is made by a process, without side reactions, which includes (a) reacting castor oil and cyclic carboxylic acid anhydride at a temperature of 75-120° C. for 4 to 24 hours, and then (b) continuing the reaction at room temperature for at least 1 week to react any remaining maleic anhydride. Skin and hair care formulations of such adducts are also described.
Patent AT-E286539-T1 (AT)
Inventor: NAUGHTON ANDREW
IPC: C12P41/00
Filed: 2000-02-23
Granted: 2005-01-15
Abstract: The invention relates to a novel method for the preparation of optically active 3,3,3-trifluoromethyl-2-alkyl propionic acid derivatives of the general formulae (I) and (II), in which R is ethyl or methyl and X is OH or NH2, provided that if R is methyl X<>  -OH. The method comprises the reaction of a racemic propionic acid amide of the general formula (III) either by means of microorganisms which are able to use the propionic acid amide in the form of the racemate or one of its optically active isomers as the only nitrogen source or by means of a polypeptide with amidohydrolase activity which is able to hydrolyze the propionic acid amide. The invention also relates to new optically active representatives of this category of compounds.
Patent AT-E368122-T1 (AT)
Inventor: NALDINI LUIGI
IPC: C12N15/09
Filed: 2000-04-26
Granted: 2007-08-15
Abstract: Lentiviral vectors modified at the 5' and 3' LTR are useful in the production of recombinant lentivirus vectors. Such vectors can be produced in the absence of a functional tat gene.
Patent AT-E275973-T1 (AT)
Inventor: GRUBB GARY S
IPC: A61K31/567
Filed: 2000-05-01
Granted: 2004-10-15
Abstract: This invention relates to cyclic combination therapies and regimens utilizing substituted indoline derivative compounds which are antagonists of the progesterone receptor having general structure (I): wherein R<1> and R<2> may be single substituents or fused to form spirocyclic or hetero-spirocyclic rings; R<3> is H, OH, NH2, C1 to C6 alkyl, substituted C1 to C6 alkyl, C3 to C6 alkenyl, substituted C1 to C6 alkenyl, alkynyl, or substituted alkynyl, COR<C>; R<C> is H, C1 to C3 alkyl, substituted C1 to C3 alkyl, aryl, substituted aryl, C1 to C3 alkoxy, substituted C1 to C3 alkoxy, C1 to C3 aminoalkyl, or substituted C1 to C3 aminoalkyl; R<4> is H, halogen, CN, NO2, C1 to C6 alkyl, substituted C1 to C6 alkyl, alkynyl, or substituted alkynyl, C1 to C6 alkoxy, substituted C1 to C6 alkoxy, amino, C1 to C6 aminoalkyl, or substituted C1 to C6 aminoalkyl; and R<5> is selected from a trisubstituted benzene ring of a five or six membered ring with 1, 2, or 3 heteroatoms from the group including O, S, SO, SO2 or NR<6> and containing one or two independent substituents from the group including H, halogen, CN, NO2 , amino, and C1 to C3 alkyl, C1 to C3 alkoxy, C1 to C3 aminoalkyl, COR<F>, or NR<G>COR<F>; or pharmaceutically acceptable salt thereof. These methods of treatment may be used for contraception or for the treatment and/or prevention of secondary amenorrhea, dysfunctional bleeding, uterine leiomyomata, endometriosis; polycystic ovary syndrome, carcinomas and adenocarcinomas of the endormetrium, ovary, breast, colon, prostate, or minimization of side effects or cyclic menstrual bleeding. Additional uses of the invention inlcude stimulation of food intake.
Patent AT-E437913-T1 (AT)
Inventor: HIRATA MASUMI
IPC: C08K5/00
Filed: 2000-05-24
Granted: 2009-08-15
Abstract: A polycarbonate resin composition which is excellent in thermal stability such as color retention at the time of melt molding, for example, the prevention of yellowing, and moldability such as releasability and transferability and therefore particularly suitable for the production of precision optical moldings such as optical disk substrates and lenses. The polycarbonate resin composition comprises (A) an aromatic polycarbonate, and (B) a cyclic carbonate compound, a monoester compound of a divalent aliphatic alcohol having 3 to 14 carbon atoms and an aliphatic monocarboxylic acid having 12 to 24 carbon atoms, or an ether compound obtained by converting at least one hydroxyl group of a polyvalent aliphatic alcohol having 3 to 14 carbon atoms into an aliphatic oxy group having 1 to 18 carbon atoms, or (C) a partial ester compound of an aliphatic alcohol having a valence of 2 to 6 and 2 to 14 carbon atoms and an aliphatic monocarboxylic acid having 12 to 24 carbon atoms, a cyclic phenol compound or a compound selected from hydrochloric acid, phosphoric acid, phosphorous acid, boric acid, and amine salts and ammonium salts thereof.